Do you think it is the same case for 10x? Both, PACB and TXG, trended similarly recently. TXG seems to be more cash-rich. What do you think, which one had a larger defensible moat?
@@ShareTreck ...TXG stock started the decline much before that news. I think fundamentals and technicals are more important in TXG's case than news and sentiment. Half of wall street doesn't understand biotech.
Many thanks 🙏
🙏 most welcome!
Thanks for your thoughts.🙏
🙏
Do you think it is the same case for 10x? Both, PACB and TXG, trended similarly recently. TXG seems to be more cash-rich. What do you think, which one had a larger defensible moat?
10X had a problem due to acquisition of Fluent by Illumina- that is my understanding.
@@ShareTreck ...TXG stock started the decline much before that news. I think fundamentals and technicals are more important in TXG's case than news and sentiment. Half of wall street doesn't understand biotech.